Products Categories
CAS No.: | 2347-80-0 |
---|---|
Name: | Thioproperazine dimesylate |
Molecular Structure: | |
Formula: | C22H30N4O2S2.2(CH4O3S) |
Molecular Weight: | 638.84 |
Synonyms: | Thioproperazine dimethanesulfonate; |
EINECS: | 219-074-2 |
Melting Point: | 218-222°C |
Boiling Point: | 612.2 °C at 760 mmHg |
Flash Point: | 324 °C |
Hazard Symbols: | Xn |
PSA: | 206.28000 |
LogP: | 5.36830 |
What can I do for you?
Get Best Price
The Thioproperazine dimesylate, with the CAS registry number of 2347-80-0, is also known as Thioproperazine dimethanesulfonate. It belongs to the product category of Organics. Its EINECS registry number is 219-074-2. This chemical's molecular formula is C22H30N4O2S2.2CH4O3S and molecular weight is 638.85. What's more, its IUPAC name is N,N-Dimethyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine-. This chemical's classification codes are Drug / Therapeutic Agent; Mutation data.
Physical properties about the Thioproperazine dimesylate are: (1)ACD/LogP: 3.17; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.69; (4)ACD/LogD (pH 7.4): 2.4; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 25.67; (7)ACD/KOC (pH 5.5): 4.17; (8)ACD/KOC (pH 7.4): 214.79; (9)#H bond acceptors: 6; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 6; (12)Polar Surface Area: 80.78 Å2; (13)Flash Point: 324 °C; (14)Enthalpy of Vaporization: 90.88 kJ/mol; (15)Boiling Point: 612.2 °C at 760 mmHg; (16)Vapour Pressure: 6.32E-15 mmHg at 25 °C.
You can still convert the following datas into molecular structure:
(1) SMILES:O=S(=O)(O)C.O=S(=O)(O)C.O=S(=O)(N(C)C)c2cc1N(c3c(Sc1cc2)cccc3)CCCN4CCN(C)CC4
(2) InChI:InChI=1/C22H30N4O2S2.2CH4O3S/c1-23(2)30(27,28)18-9-10-22-20(17-18)26(19-7-4-5-8-21(19)29-22)12-6-11-25-15-13-24(3)14-16-25;2*1-5(2,3)4/h4-5,7-10,17H,6,11-16H2,1-3H3;2*1H3,(H,2,3,4)
(3) InChIKey:QPMDKXBBAVQDCB-UHFFFAOYAR7
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 115mg/kg (115mg/kg) | Psychopharmacologia Vol. 12, Pg. 142, 1968. Link to PubMed | |
mouse | LD50 | intravenous | 70mg/kg (70mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 52, 1972. | |
mouse | LD50 | oral | 800mg/kg (800mg/kg) | Drugs in Japan Vol. 6, Pg. 456, 1982. | |
mouse | LD50 | subcutaneous | 500mg/kg (500mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 52, 1972. | |
rat | LD50 | intraperitoneal | 59mg/kg (59mg/kg) | Psychopharmacologia Vol. 12, Pg. 142, 1968. Link to PubMed | |
rat | LD50 | intravenous | 45mg/kg (45mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 52, 1972. | |
rat | LD50 | oral | 750mg/kg (750mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 52, 1972. | |
rat | LD50 | subcutaneous | 1250mg/kg (1250mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 52, 1972. |